VERU Stock Research

Today

Veru reports Q3 EPS (30c) vs. (50c) last year

VERU

6:36 AM

Over a week ago

Veru completes enrollment in PLATEAU clinical study

VERU

Jul 27, 9:06 AM

Veru pact with Novo 'significant event,' says Canaccord

Jun 4, 12:40 PM

Veru announces clinical supply agreement with Novo Nordisk

Jun 4, 12:38 PM

Veru price target lowered by $1 at Oppenheimer, here's why

VERU

May 15, 7:44 AM

Veru reports Q2 EPS (37c) vs. ($1.15) last year

VERU

May 13, 6:37 AM

Veru files $200M mixed securities shelf

VERU

Apr 7, 4:22 PM

Veru files to sell 23.8M shares of common stock

VERU

Apr 7, 4:16 PM

Veru enrolls first patient in Phase 2b PLATEAU trial of enobosarm

VERU

Mar 9, 8:34 AM

Veru reports Q1 EPS (26c) vs. (61c) last year

VERU

Feb 11, 7:20 AM

Veru initiated with bullish view at Canaccord, here's why

VERU

Dec 18, 6:05 AM

Veru prices 1.4M shares at $3.00 in underwritten public offering

VERU

Oct 30, 8:25 AM

Veru announces pricing of $25M public offering

VERU

Oct 30, 8:23 AM

Veru announces offering of common stock and warrants, no amount given

VERU

Oct 29, 4:05 PM

Onconetix announces financing through private placement, debt settlement

Sep 26, 8:35 AM

Veru announces FDA meeting providing regulatory clarity for Enobosarm

VERU

Sep 23, 8:31 AM

Veru reports Q3 EPS (50c) vs. (75c) last year

VERU

Aug 12, 6:32 AM

Veru announces selection of modified release of enobosarm for PK study

VERU

Aug 11, 8:33 AM

No more stories